Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850.
Spencer KR, Portal DE, Aisner J, Stein MN, Malhotra J, Shih W, Chan N, Silk AW, Ganesan S, Goodin S, Gounder M, Lin H, Li J, Cerchio R, Marinaro C, Chen S, Mehnert JM. Spencer KR, et al. Among authors: aisner j. Oncotarget. 2023 Apr 10;14:302-315. doi: 10.18632/oncotarget.28403. Oncotarget. 2023. PMID: 37036756 Free PMC article. Clinical Trial.
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies.
Tan AR, Chan N, Kiesel BF, Stein MN, Moss RA, Malhotra J, Aisner J, Shah M, Gounder M, Lin H, Kane MP, Lin Y, Ji J, Chen A, Beumer JH, Mehnert JM. Tan AR, et al. Among authors: aisner j. Cancer Chemother Pharmacol. 2022 Jan;89(1):49-58. doi: 10.1007/s00280-021-04350-x. Epub 2021 Oct 20. Cancer Chemother Pharmacol. 2022. PMID: 34669023 Free PMC article. Clinical Trial.
Overexpression of excision repair cross-complementing 1 gene associates with higher risk of therapeutic failure after definitive chemoradiation for unresectable non-small cell lung cancer.
Deek MP, Yegya-Raman N, Daroui P, Balasubramanian S, Malhotra J, Moore D, Patel M, Wang SJ, Aisner J, Jabbour SK. Deek MP, et al. Among authors: aisner j. Ann Palliat Med. 2021 Jul;10(7):7205-7213. doi: 10.21037/apm-21-182. Epub 2021 Jun 26. Ann Palliat Med. 2021. PMID: 34263627 Free PMC article.
Tumor volume reduction evaluated by cone beam computed tomography during stereotactic body radiotherapy for early stage non-small cell lung cancer.
Gaines DK, Yegya-Raman N, Kim S, Simone CB 2nd, Theodorou Ross C, Deek MP, Lam S, Feigenberg SJ, Osorio B, Nie K, Zou W, Patel M, Malhotra J, Langenfeld J, Aisner J, Jabbour SK. Gaines DK, et al. Among authors: aisner j. J Thorac Dis. 2020 May;12(5):2482-2488. doi: 10.21037/jtd.2020.03.46. J Thorac Dis. 2020. PMID: 32642155 Free PMC article.
Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer.
Babiker HM, Milhem M, Aisner J, Edenfield W, Shepard D, Savona M, Iyer S, Abdelrahim M, Beach CL, Skikne B, Laille E, Tsai KT, Ho T. Babiker HM, et al. Among authors: aisner j. Cancer Chemother Pharmacol. 2020 May;85(5):1009-1010. doi: 10.1007/s00280-020-04056-6. Cancer Chemother Pharmacol. 2020. PMID: 32215699 Free PMC article.
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial.
Jabbour SK, Berman AT, Decker RH, Lin Y, Feigenberg SJ, Gettinger SN, Aggarwal C, Langer CJ, Simone CB 2nd, Bradley JD, Aisner J, Malhotra J. Jabbour SK, et al. Among authors: aisner j. JAMA Oncol. 2020 Jun 1;6(6):848-855. doi: 10.1001/jamaoncol.2019.6731. JAMA Oncol. 2020. PMID: 32077891 Free PMC article. Clinical Trial.
306 results